Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection

Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection

Neuropeptide Y (NPY) and related peptides have been proposed as promising biomarkers for the diagnosis of prostate cancer by previous immunoassays and immunohistochemical studies. In this study, we evaluated the additional value of NPY and related peptides compared with prostate-specific antigen (PS...

Full description

Bibliographic Details
Main Authors: Jonathan Maurer, Philippe J. Eugster, Kiana Collins, Céline Vocat, Jason Oke, Brian Nicholson, Arnas Rakauskas, Eric Grouzmann, Massimo Valerio
Format: Article
Language:English
Published: Elsevier 2024-08-01
Series:European Urology Open Science
Subjects:
Biomarker
Diagnosis
Neuropeptide Y
Pro-neuropeptide Y
Prostate cancer
Prostate-specific antigen
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168324004646

Internet

http://www.sciencedirect.com/science/article/pii/S2666168324004646

Similar Items